tetano
Editor, Senior Moderator
JBRA Assist Reprod. 2020 May 1;24(2):219-225. doi: 10.5935/1518-0557.20200030.
A review of initial data on pregnancy during the COVID-19 outbreak: implications for assisted reproductive treatments.
Monteleone PA[SUP]1,[/SUP][SUP]2[/SUP], Nakano M[SUP]1,[/SUP][SUP]2[/SUP], Lazar V[SUP]1[/SUP], Gomes AP[SUP]1[/SUP], de H Martin[SUP]1,[/SUP][SUP]2[/SUP], Bonetti TC[SUP]1,[/SUP][SUP]3[/SUP].
Author information
Abstract
The current outbreak of the novel 2019 coronavirus disease (COVID-19) started in China in December 2019 and has since spread to several other countries. On March 25, 2020, a total of 375,498 cases had been confirmed globally with 2,201 cases in Brazil, showing the urgency of reacting to this international public health emergency. While in most cases, mild symptoms are observed, in some cases the infection leads to serious pulmonary disease. As a result, the possible consequences of the COVID-19 outbreak for pregnant women and its potential effects on the management of assisted reproductive treatments, demand attention. In this review, we summarize the latest research progress related to COVID-19 epidemiology and the reported data of pregnant women, and discuss the current evidence of COVID-19 infections during pregnancy and its potential consequences for assisted reproductive treatments. Reported data suggest that symptoms in pregnant women are similar to those in other people, and that there is no evidence for higher maternal or fetal risks. However, considering the initial data and lack of comprehensive knowledge on the pathogenesis of SARS-CoV-2 during pregnancy, human reproduction societies have recommended postponing the embryo transfers and do not initiate new treatment cycles. New evidence must be considered carefully in order to adjust these recommendations accordingly at any time and to guide assisted reproductive treatments.
KEYWORDS:
COVID-19; SARS-CoV-2; assisted reproduction; pregnancy
PMID:32301600DOI:10.5935/1518-0557.20200030
A review of initial data on pregnancy during the COVID-19 outbreak: implications for assisted reproductive treatments.
Monteleone PA[SUP]1,[/SUP][SUP]2[/SUP], Nakano M[SUP]1,[/SUP][SUP]2[/SUP], Lazar V[SUP]1[/SUP], Gomes AP[SUP]1[/SUP], de H Martin[SUP]1,[/SUP][SUP]2[/SUP], Bonetti TC[SUP]1,[/SUP][SUP]3[/SUP].
Author information
Abstract
The current outbreak of the novel 2019 coronavirus disease (COVID-19) started in China in December 2019 and has since spread to several other countries. On March 25, 2020, a total of 375,498 cases had been confirmed globally with 2,201 cases in Brazil, showing the urgency of reacting to this international public health emergency. While in most cases, mild symptoms are observed, in some cases the infection leads to serious pulmonary disease. As a result, the possible consequences of the COVID-19 outbreak for pregnant women and its potential effects on the management of assisted reproductive treatments, demand attention. In this review, we summarize the latest research progress related to COVID-19 epidemiology and the reported data of pregnant women, and discuss the current evidence of COVID-19 infections during pregnancy and its potential consequences for assisted reproductive treatments. Reported data suggest that symptoms in pregnant women are similar to those in other people, and that there is no evidence for higher maternal or fetal risks. However, considering the initial data and lack of comprehensive knowledge on the pathogenesis of SARS-CoV-2 during pregnancy, human reproduction societies have recommended postponing the embryo transfers and do not initiate new treatment cycles. New evidence must be considered carefully in order to adjust these recommendations accordingly at any time and to guide assisted reproductive treatments.
KEYWORDS:
COVID-19; SARS-CoV-2; assisted reproduction; pregnancy
PMID:32301600DOI:10.5935/1518-0557.20200030